With the runaway success of phakic IOLs in the Asia-Pacific region, more—and varied— refractive patients are flocking to clinics to have the procedure done. So how can ophthalmologists optimize patient outcomes with EVO ICL™️ in these high volume situations? Join us at the STAAR Surgical 3rd EVO ICL APAC Experts Summit as we turn to the elite AIER Eye Hospital Group in China and Dr. Jin Zhou, their deputy lead of refractive surgery, for key insights on how to maintain high patient satisfaction in a thriving ICL practice.
Discover why Dr. Zhou, with 20 years of ICL experience and nearly 37,000 surgeries, continues to choose EVO ICL for her patients, and how she has kept patients coming through the doors of AIER over the years. From treating high myopes to now increasingly using EVO for lower levels of myopia, learn how her approach has evolved and why EVO ICL stands out in the realm of refractive surgery. Don’t miss out on these key lessons from one of China’s most influential ICL practitioners—and visit www.discovericl.com for more information!
*Published content is intended for healthcare professionals only*
